Source:http://linkedlifedata.com/resource/pubmed/id/11291081
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2001-4-6
|
pubmed:abstractText |
Peripheral gammadelta T cells derived from healthy donors were found to exhibit cytotoxicity against a variety of tumor cell lines in vitro, including CNE2, which was established from nasopharyngeal carcinoma (NPC). The anti-tumor effects were further studied in a mouse model. Control nude mice inoculated s.c. with 5 x 10(6) CNE2 cells regularly developed hypodermal tumors, which progressively increased in size, and animals had a mean survival of 35 +/- 3.4 days. Tumor growth was arrested and tumor size was reduced after animals were infused with 5 x 10(7) gammadelta T cells derived from a healthy donor. The anti-tumor effects were temporary, however, and tumor growth was resumed after about 1 week in a group of the animals that had been given a single dose of gammadelta T cells. In another group of animals given 2 doses of gammadelta cells 1 week apart, resumption of tumor growth was delayed for a further week. Mean survival of the 2 groups was increased to 61 +/- 15.7 and 74 +/- 12.9 days, respectively. Immunohistology revealed an accumulation of infused cells in tumors attended by focal tumor necrosis in specimens taken 2 days after infusion. Infiltrative cells virtually disappeared from tumor tissues 6 days after infusion, accompanied by increased mitotic indices of tumor cells. These temporal relationships suggested that the accumulation of infused gammadelta T cells in hypodermal tumors was responsible for the observed anti-tumor effects.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0020-7136
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2001 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
92
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
421-5
|
pubmed:dateRevised |
2007-7-24
|
pubmed:meshHeading |
pubmed-meshheading:11291081-Animals,
pubmed-meshheading:11291081-Disease Models, Animal,
pubmed-meshheading:11291081-Immunotherapy,
pubmed-meshheading:11291081-Lymphocytes, Tumor-Infiltrating,
pubmed-meshheading:11291081-Mice,
pubmed-meshheading:11291081-Mice, Inbred BALB C,
pubmed-meshheading:11291081-Mice, Nude,
pubmed-meshheading:11291081-Neoplasm Transplantation,
pubmed-meshheading:11291081-Neoplasms, Experimental,
pubmed-meshheading:11291081-Receptors, Antigen, T-Cell, gamma-delta,
pubmed-meshheading:11291081-T-Lymphocytes,
pubmed-meshheading:11291081-Tumor Cells, Cultured
|
pubmed:year |
2001
|
pubmed:articleTitle |
Anti-tumor effects of human peripheral gammadelta T cells in a mouse tumor model.
|
pubmed:affiliation |
Department of Microbiology, University of Hong Kong, Hong Kong.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|